We are pleased to announce that our company has been selected to participate in the “IP Acceleration program for Startups (IPAS)”, an IP acceleration program by the Japan Patent Office for fiscal year 2022. Through this program, we will establish an advanced IP strategy for disease diagnostics based on “Single-molecule Enzyme Activity-based Protein Profiling (SEAP)” technology, and aim to further accelerate our business.

List of IPAS2022 adopted companies: https://ipbase.go.jp/news/2022/08/news-0808-2.php Video of our introduction at the kick-off event (2:05:00~): https://www.youtube.com/watch?v=ff-RfhMIRcQ

<What is IPAS?>

IPAS is a program consisting of a team of experts in business and intellectual property who support startups build appropriate business models, product strategies, etc., and IP strategies for their businesses. Within the 5-month mentoring period, the startups organize their company’s current situation, ideas, and issues and provide them to the mentors, and together the company and mentors build a “management x IP” strategy, ultimately aiming for business growth.